EDITORIAL SECTION

Articles

Leveraging Blockchain for Drug Traceability and Security in Europe

The area of interest in the pharmaceutical products in the past couple of years has been in the area of traceability and security Recently there has been an increase in fake drugs as well as advanced supply chain management making it difficult to tell the actual quality of the manufactured drugs

Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security

For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February that model has been law across the European Union and it has worked better than many sceptics predicte...

The Future of Pharma Data Management: Creating Unified Platforms for Innovation

Ask a European pharmaceutical executive where the companys data actually lives and the honest answer is usually in about forty places under a dozen owners described in half a dozen vocabularies Research holds assay and translational data Clinical holds trial and subject data

How Quantum Computing Is Transforming Drug Discovery

The current medical setting sees technology lead drug development towards faster speeds Quantum computing in drug discovery belongs to an exclusive group of technological advances that drives revolutionary change in science The advanced computational model called quantum computing drives innovation in drug discovery as well as drug testing and pharmaceutical market release Scientists and experts n...

Beyond Trial Completion: Post-Trial Responsibilities and Effective Dissemination of Clinical Research

Clinical trials are the cornerstone of evidencebased medicine and pharmaceutical innovation Through the systematic evaluation of interventions they provide the evidence required to assess efficacy safety and value for patients and healthcare systems However the completion of participant followup does not signify the completion of a trials ethical and scientific obligations

A Closer Look at Pharmacological Interventions: Treatment Overview

Pharmacological interventions are a cornerstone of modern healthcare encompassing a diverse array of medications designed to treat alleviate or prevent various medical conditions

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys